Geode Capital Management LLC lifted its position in Vigil Neuroscience, Inc. (NASDAQ:VIGL – Free Report) by 41.9% during the 3rd quarter, HoldingsChannel reports. The firm owned 226,083 shares of the ...

Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.

Neuroscience Innovation Forum14th Annual LifeSci Advisors Corporate Access EventInvest Securities BioMed Forum 2025MidCap Events ...

The stock market saw something incredible in 2024, with the “Magnificent 7” tech giants leading the charge and driving a huge ...

Mytos’ technology will automate the manufacturing of neuronal precursors for Aspen's autologous cell therapy for the brain disorder.

Neuroprosthetics research has entered a stage in which animal models and proof-of-concept studies are translated into ...

Mytos, an innovative leader in automated cell manufacturing, has entered into a manufacturing collaboration with Aspen ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

A study of over 1,000 employees found that sedentary jobs and nontraditional work schedules significantly increase the risk ...

Artificial intelligence continues to push the boundaries of science and health exploration. From mapping proteins to neurological networks, these systems continue to make game-changing impacts on the ...

On a recent visit to Washington DC, Ho sat down with GEN Editorial Director Kevin Davies, PhD, to discuss Denali’s progress ...